Early Development Leader
The Early Development Leader (EDL) is a high-responsibility, strategic role, critical for developing the vision and trajectory for a medicine that maximizes its opportunity for GSK and benefit for patients.
The EDL is the single point of accountability to lead the development of a medicine from initiation of Lead Optimization through Proof of Concept (PoC), defining the criteria necessary to identify and progress game-changing medicines through creative and innovative experimental design.
By working with various stakeholders across R&D, the EDL obtains and manages associated resources and delivers evidence in line with the strategic vision and organizational strategy to support progression beyond PoC for a clearly differentiated medicine.
Key Responsibilities
Leadership of the Early Development Strategy :
- Contributes to and establishes the development strategy to support the Medicine Profile (MP)
- Secures input and alignment from late-stage Development, Commercial and Medical
- Ensures asset development strategy is kept current, as internal priorities shift and the external landscape changes
Matrix Leadership of the Early Development Team (EDT) :
Leads the multi-disciplinary Early Development matrix team and owns the performance of the EDTMakes clear and timely evidence-based accelerate / go / no-go decisions in line with the strategyEnsures excellence in execution of all governance processesPrioritizes activities and manages the early development plan to meet budget constraintsEnsures team accountabilities, including study oversight, pharmacovigilance, scientific engagement and promotional practices are in line with the development strategy and GSK expectationsDelivers the package of evidence that supports the MP for a medicine of valueModels GSK values and leadership expectationsBusiness Partnering beyond the EDT :
Provides significant input in selecting members of the EDT, in consultation with the Functional Line leaders, supporting differentiated development for team membersStrategically partners with Functional Line Heads to ensure alignment with organizational priorities and to maximize the asset's portfolio options including developing multiple indicationsProvides key support to the Project Team (PT) in the lead up to the Commit to Lead Optimization milestone and to the Medicines Development Team (MDT) following achievement of PoC to ensure end-to-end alignment on the drug development strategyWorks closely with the Project Leader (PL) and Medicine Development Leader (MDL) to ensure smooth transitions from the PL ahead of Commit to Lead Optimization and to the MDL upon achieving PoCBasic Qualifications
We are looking for professionals with these required skills to achieve our goals :
Advanced degree such as PhD, MD, PharmD, MBA or equivalent is requiredMinimum of 10 years drug development experience in the pharmaceutical industry - Must demonstrate deep drug development expertiseProven ability to think and plan strategically and to work with members of other functions within a matrix environment utilizing well-developed leadership and stakeholder management skillsUnderstands the relevance of early-stage questions, including tools and methodologies for addressing the questions : "learning about the asset" and appreciates limitations and strengths of the pre-clinical settingDemonstrates thorough translational understanding (pre-clinical / clinical)Pre-clinical and clinical development experience (end-to-end knowledge)Preferred Qualifications
If you have the following characteristics, it would be a plus :
Experience or expertise in Immuno-Inflammation, Respiratory, Hepatology, GI, Renal, Connective Tissue or neurodegenerative diseases areasExperience as a matrix leader able to work across technical disciplines and integrate requirements from matrix partners into a coherent evidence-generation and forward planExperience or clear familiarity / understanding of the attributes of early clinical development and importance of clinical pharmacology, modelling & simulation and statisticsExperience gathering early commercial insights and awareness of the impact of external factors, e.g., public policy, competitor landscapePrior significant pre-clinical and clinical expertise in drug development with an emphasis on earlier stage clinical development and translational medicineExpertise / knowledge in translational medicine / experimental medicine design and managementStrong understanding of options for regulatory pathways, Life Cycle Management and sequencing of indicationsKnowledge of manufacturing compliance and regulatory requirementsWhy GSK?
Our values and expectations are at the heart of everything we do and form an important part of our culture. These include Patient focus, Transparency, Respect, Integrity along with Courage, Accountability, Development, and Teamwork. As GSK focuses on our values and expectations and a culture of innovation, performance, and trust.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas : respiratory, immunology and inflammation; oncology; HIV; and infectious diseases to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
